Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.
NexCure offers clinically intense therapies in outpatient, community settings, and other cutting-edge treatments.
Candid Therapeutics is a biotechnology company that focuses on the treatment of a range of immunological conditions.
Zura Bio is a clinical-stage, multi-asset biotechnology company.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Slate Medicines develops therapeutics that target Pituitary Adenylate Cyclase-Activating Polypeptide for migraine treatment and prevention.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.
Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.
Apeiron labs mission is to provide data from the upper of the ocean.
Avalanche Energy is a fusion energy startup that develops micro-fusion reactors for distributed energy and mobility.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
Kinaset Therapeutics is a biopharma company that focuses on advancement of novel drugs in areas of unmet medical needs.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
RA Capital Management has invested in 467 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Therapeutics, Health Care, Life Science, Medical. The firm invests across 18 different industry categories.
Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. RA Capital Management's total known invested capital is $56.7B.
RA Capital Management's average investment size is $123.5M across its portfolio of 467 companies.
Recent RA Capital Management portfolio additions include SAB Biotherapeutics, Equillium, Solid Biosciences, Atavistik Bio, NexCure. These companies were founded in 2020 or later.